SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management
L Wu, AM O'Kane, H Peng, Y Bi, D Motriuk-Smith… - Biochemical …, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of …
syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of …
Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment
J Luo, X Zhu, J Jian, X Chen… - Acta biochimica et …, 2021 - academic.oup.com
Abstract The coronavirus disease-2019 (COVID-19) caused by the novel coronavirus severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly developed into a …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly developed into a …
Cardiovascular complications associated with COVID-19 and potential therapeutic strategies
A Samidurai, A Das - International journal of molecular sciences, 2020 - mdpi.com
The outbreak of coronavirus disease 2019 (COVID-19), an infectious disease with severe
acute respiratory syndrome, has now become a worldwide pandemic. Despite the …
acute respiratory syndrome, has now become a worldwide pandemic. Despite the …
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
Impact of COVID-19 on the cardiovascular system: a review of available reports
RS Soumya, TG Unni, KG Raghu - Cardiovascular drugs and therapy, 2021 - Springer
The recent emergence of the coronavirus disease 19 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in China is now a global health …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in China is now a global health …
COVID-19 and cardiovascular disease: from bench to bedside
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …
consequences on the cardiovascular health of millions of people who survive infection …
Cardiovascular complications of COVID-19: pharmacotherapy perspective
Abstract Coronavirus disease of 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly the world over. The …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly the world over. The …
Cardiovascular risks in patients with COVID-19: potential mechanisms and areas of uncertainty
Abstract Purpose of Review COronaVirus Disease 2019 (COVID-19) has spread at
unprecedented speed and scale into a global pandemic with cardiovascular risk factors and …
unprecedented speed and scale into a global pandemic with cardiovascular risk factors and …
Cardiovascular implications of the COVID-19 pandemic: a global perspective
M Boukhris, A Hillani, F Moroni, MS Annabi… - Canadian Journal of …, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …
相关搜索
- molecular mechanisms sars cov
- pharmaceutical management sars cov
- molecular mechanisms pharmaceutical management
- covid 19 cardiovascular complications
- covid 19 cardiovascular disease
- covid 19 cardiovascular risks
- covid 19 basic mechanisms
- covid 19 cardiovascular pathology
- covid 19 pharmacotherapy perspective
- covid 19 clinical perspectives
- pharmacotherapy perspective cardiovascular complications
- basic mechanisms cardiovascular disease
- clinical perspectives cardiovascular disease
- clinical perspectives basic mechanisms